ClinicalTrials.Veeva

Menu

Frequency of Residual Neuromuscular Blockade in the Pediatric Population

Nationwide Children's Hospital logo

Nationwide Children's Hospital

Status

Terminated

Conditions

Neuromuscular Blockade

Treatments

Procedure: Neuromuscular blockade

Study type

Observational

Funder types

Other

Identifiers

NCT01786863
IRB13-00045

Details and patient eligibility

About

This study is designed to investigate the frequency of Residual Neuromuscular Blockade (RNMB) in the pediatric population.

Full description

The proposed study will be the first to investigate the incidence of residual postoperative neuromuscular blockade in the pediatric patient following the intraoperative use of NMBA's. If there is significant residual blockade present, it may be that these effects will lead to postoperative respiratory complications including hypoxemia, atelectasis, and prolonged oxygen requirement resulting in a prolonged stay in the post-anesthesia care unit.

Enrollment

5 patients

Sex

All

Ages

Under 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age less than 18 years.
  2. Surgery requiring the administration of neuromuscular blocking, agents with planned extubation in the postoperative care unit (PACU).

Exclusion criteria

  1. Neuromuscular diseases which may prolong the duration of NMBA's or exaggerate the effects of residual blockade.
  2. The need for postoperative mechanical ventilation.
  3. Direct admission to the Pediatric ICU, NICU or CTICU.

Trial design

5 participants in 1 patient group

Neuromuscular blockade
Treatment:
Procedure: Neuromuscular blockade

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems